Trial intelligence / Profile preview

Letrozole for Ectopic Pregnancy

NCT05198141Phase 4Completed

Sponsor
Zagazig University
Start
Dec 2020
Primary completion
Nov 2021
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 4, randomised, open-label trial of letrozole in Ectopic pregnancy (EP) (3 arms), sponsored by Zagazig University. Primary endpoint: Human Chorionic Gonadotropin at day 11. Started Dec 2020; status: completed.

02

Drugs

letrozole
03

Conditions

Ectopic pregnancy (EP)

Beyond the preview

Go deeper on NCT05198141.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05198141.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call